Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …

Lipoprotein (a)(Lp (a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) …

Lipoprotein (a)[Lp (a)] is an independent but moderate, predictor for coronary heart disease
(CHD) prevalence and severity. Several established and emerging cardiovascular (CV) risk …

It is widely accepted that elevated levels of lipoprotein (a)(Lp (a)) are associated with an
increased risk for cardiovascular diseases. Several studies have identified Lp (a) as …

Lipoprotein (a) or lipoprotein “little a”[Lp (a)] is an under-recognized causal risk factor for
cardiovascular (CV) disease (CVD), including coronary atherosclerosis, aortic valvular …

Advances in several fields of cardiovascular (CV) medicine have produced new treatments
(eg to treat dyslipidaemia) that have proven efficacy in terms of reducing deaths and …

Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …

Abstract Background and aims The European Atherosclerosis Society (EAS) Lipid Clinics
Network promoted a survey in order to identify and understand how and when lipoprotein …

Introduction: Recent advances in genetics and epidemiology have once again thrust
lipoprotein (a)(Lp (a)) into the clinical spotlight. Elevated plasma concentrations of Lp (a) are …

Aims To investigate the population attributable fraction due to elevated lipoprotein (a)(Lp (a))
and the utility of measuring Lp (a) in cardiovascular disease (CVD) risk prediction. Methods …